focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

Share Price Information for Ovoca Bio (OVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.65
Ask: 0.80
Change: 0.00 (0.00%)
Spread: 0.15 (23.077%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.725
OVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

15 Sep 2017 07:00

RNS Number : 8064Q
Ovoca Gold PLC
15 September 2017
 

Ovoca Gold PLC

15 September 2017

 

Ovoca Gold plc ("Ovoca" or the "Company")

2017 Interim Results

 

Ovoca Gold is pleased to announce its interim financial statements and report covering the six-month period from 1 January 2017 to 30 June 2017.

Please click on the following link to view the full Half Year Report:

http://www.rns-pdf.londonstockexchange.com/rns/8064Q_-2017-9-14.pdf

 

Highlights:

 

• Cash and cash equivalents and available for sale financial assets of €21.4 million asat 30 June 2017;

• Total comprehensive loss for the six-month period to June 30 2017 of €1.2 million;

• Dividend income received during the period of €0.3 million from our holding of Polymetal International Plc shares; and

• Cash payment of €0.5 million received during the period relating to the sale of mining equipment.

 

 

 

 

CEO's statement

Dear shareholders,

It is my pleasure to report to you our financials and the results of our work for the first half of 2017.

During the first half of the year, we completed the disposal of mining equipment for consideration of approximately €0.5 million and continued with our search for an investor for the Stakhanovsky project.

During the period we also remained very active with litigation regarding our outstanding loan to Taymura LLC, which was declared bankrupt by a Russian court order in February 2016. In accordance with Russian law, all assets of Taymura LLC were valued by an independent auditor, and subsequently divided into two main categories of assets, namely: 1) oil extraction and production equipment, including the license (valued at approximately US$11 million); and 2) oil products (diesel, gasoline, etc.) stored in stock reservoirs on site (valued at approximately US$1.3 million). Taymura LLC also has receivables (of approximately US$2.5 million) which are also the subject of litigation.

The first group of assets were placed in an auction process in May 2017; as there were no participants in this first auction process, it was lapsed. The second auction for the first group of assets was originally scheduled to take place on 15th August 2017 at an initial price equal to US$10 million. However, this auction is currently suspended pursuant to a court decision. Beneficiaries of Taymura LLC have continued to use unconstructive tactics in the courts in order to try and cancel the auction process and to seek to remove Ovoca from the register of creditors and these activities have led to a delay in the bankruptcy procedures. Separately, Taymura LLC disposed of the second group of assets in August 2017 for US$1.3 million and the proceeds received from this disposal were applied to cover the register of current debt, including salaries of ex-employees of Taymura.

Ovoca continues to pursue its legal options in order to protect its interests in the bankruptcy procedure and to enable the disposal of Taymura assets through the proposed auction at the market price.

 

Sincerely,

Kirill Golovanov

CEO

 

 

ENDS

 

Enquiries:

 

Ovoca Gold plc

Kirill Golovanov, Chief Executive Officer

 

Tel: + 7 495 916 6029

Davy - NOMAD, ESM Adviser and Broker

Tel: +353 (1) 679 6363

John Frain / Daragh O'Reilly

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EALNLFLLXEFF
Date   Source Headline
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.